The Readout Loud

Latest Episodes:

Episode 18: Biotech's six-month review, how to become a day trader and soul-searching analysts Jul 05, 2018

Show notes

Adam and Damian recap the past six months in biotech. Investor and philanthropist, Sheff Station, stops by and gives tips on how to become a day trader, and analysts questioning their very existence.

Episode 17: A friendly FDA, biosimilar awkwardness and how to sell drugs in China Jun 28, 2018

Show notes

How did the FDA become so friendly to the drug industry? The thorny issue of using 23andMe to unite families separated at the border, and Rebecca explains how drugs are priced in China.

Episode 16: Sarepta's big week, Theranos' legal woes and parsing AI hype Jun 21, 2018

Show notes

Is Sarepta Therapeutics worth $10 billion? Will Theranos' Elizabeth Holmes go behind bars? And how does AI fit into biotech?

Episode 15: Problematic parties, Nitpicking NASH, and an opioid documentary from STAT Jun 14, 2018

Show notes

The problem with the topless dancers at PABNAB. Are investors overestimating the market for fatty liver drugs? And how many lives do biotech entrepreneurs get?

Episode 14: Twitter vitriol, biotech jargon, and the plight of the CEO Jun 07, 2018

Show notes

Why is Twitter so mean to Axovant? Adam teaches a crash course on biostatistics. And will sci-fi gene and cell therapies ever go mainstream.

Episode 13: Spending millions on fatty liver disease. Overhyped cancer drugs. Who goes to BIO? May 31, 2018

Show notes

Is the drug industry spending millions on a made-up disease? Have the latest cancer drugs been overhyped? And why does anyone go to BIO?

Episode 12: Ebola should worry you, again; 23andMe's World Cup whoops; Don't drink sunscreen May 24, 2018

Show notes

How worried should you be about Ebola? Can the government lower drug prices without hurting the drug industry? And is socceromics a thing? Listen this week to find out.

Episode 11: Inside the Theranos collapse, Valeant's latest legal lumps, and a few biotech hot takes May 17, 2018

Show notes

What do you call a unicorn without a horn? Is your colleague wearing a wire? And is Jentadueto a drug name or a complicated espresso drink?

Episode #10: Cohen, Trump, Novartis, oh my; Spark + Amish; Genetic testing at your doc's office? May 10, 2018

Show notes

On today's show, we dig into the no good, very bad day Novartis had when the world got wind of its ties to President Trump's personal attorney, a discussion of how the world's biggest cancer conference used to be the Wild West for investors, and an exploration of one health system's plan to bring genomics to the masses. Also STAT's Eric Boodman joins us to talk about how a pricey new gene therapy has created a fascinating situation in Amish country.

Episode #9 - Bill Gates on deadly flu, Chinese biotech bubbles, Golden State killer genetics May 03, 2018

Show notes

We talk to Bill Gates about the flu that could kill millions. Is China too enamored with biotech startups? And how do you find a cold case killer? Genetics.

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected